Reuters logo
11 天前
BRIEF-Capricor Therapeutics Q2 loss per share $0.16
2017年8月10日 / 晚上8点35分 / 11 天前

BRIEF-Capricor Therapeutics Q2 loss per share $0.16

Aug 10 (Reuters) - Capricor Therapeutics Inc

* Capricor Therapeutics reports second quarter 2017 financial results and provides corporate update

* Q2 loss per share $0.16

* Capricor Therapeutics Inc - announced statistically-significant improvements in skeletal and cardiac muscle function in patients treated with CAP-1002

* Capricor Therapeutics Inc - plans to commence clinical trial of I.V. CAP-1002 in Duchenne Muscular Dystrophy in the fourth quarter Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below